Rocket


News + Filings
Transactions





Smith Mark Alan

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
06/30/2022Vistagen Therapeutics, Inc.VTGNGrantCommon Stock5k$0.75$3.7k 06/30/2022
03/01/2022Vistagen Therapeutics, Inc.VTGNGrantStock Option (Right to Buy)150k$1.37$205.5k 03/01/2022
12/31/2021Vistagen Therapeutics, Inc.VTGNGrantCommon Stock2.7k$1.66$4.4k 12/31/2021
12/31/2020Vistagen Therapeutics, Inc.VTGNGrantCommon Stock5k$0.45$2.3k 12/30/2020
12/30/2020Vistagen Therapeutics, Inc.VTGNGrantStock Option (Right to Buy)150k$1.77$265.5k 12/30/2020
06/30/2020Vistagen Therapeutics, Inc.VTGNGrantCommon Stock5k$0.45$2.2k 06/30/2020
04/23/2020Vistagen Therapeutics, Inc.VTGNGrantStock Option (Right to Buy)150k$0.40$59.7k 04/23/2020
10/21/2019Vistagen Therapeutics, Inc.VTGNGrantStock Option (Right to Buy)100k$1.41$141k 10/21/2019
05/23/2019Vistagen Therapeutics, Inc.VTGNGrantStock Option (Right to Buy)150k$1.00$150k 05/23/2019
08/29/2018Vistagen Therapeutics, Inc.VTGNDispositionStock Option (Right to Buy)180k$3.49$628.2k 08/29/2018
08/29/2018Vistagen Therapeutics, Inc.VTGNGrantStock Option (Right to Buy)180k$1.50$270k 08/29/2018
08/29/2018Vistagen Therapeutics, Inc.VTGNDispositionStock Option (Right to Buy)80k$3.80$304k 08/29/2018
08/29/2018Vistagen Therapeutics, Inc.VTGNGrantStock Option (Right to Buy)80k$1.50$120k 08/29/2018
08/29/2018Vistagen Therapeutics, Inc.VTGNDispositionStock Option (Right to Buy)125k$1.96$245k 08/29/2018
08/29/2018Vistagen Therapeutics, Inc.VTGNGrantStock Option (Right to Buy)125k$1.50$187.5k 08/29/2018
08/05/2018Vistagen Therapeutics, Inc.VTGNGrantStock Option (Right to Buy)100k$1.27$127k 08/05/2018
02/02/2018Vistagen Therapeutics, Inc.VTGNGrantStock Option (Right to Buy)200k$1.16$232k 02/02/2018
09/19/2017Vistagen Therapeutics, Inc.VTGNGrantStock Option (Right to Buy)100k$1.56$156k 09/19/2017

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy